
    
      Clinical response will be assessed by the percentage of patients achieving a reduction from
      Baseline in Disease Activity Score 28-joint count (Erythrocyte Sedimentation Rate)
      [DAS28(ESR)] score of greater than 1.2 points, which is considered the minimum clinically
      important difference.
    
  